5.4900.00% ( 0.000 )
Delay Closed: Nov 16, 16:08:00Overview
CHARMACY PHAR (2289)
Charmacy Pharmaceutical Co., Ltd. engages in the pharmaceutical distribution business in the People’s Republic of China. It distributes western medicines, Chine...
- Open
- 5.490
- High
- 5.490
- Low
- 5.490
- Prev. Close
- 5.490
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- 0.00%
- 52wk High
- 7.300
- Volume Ratio
- 0.00
- Turnover Ratio
- --
- 52wk Low
- 3.956
- HK Mkt Cap
- 592.92M
- Market CapHKD
- 592.92M
- P/ETTM
- 10.94
- P/EDynamic
- 11.42
- P/EStatic
- --
- EPSTTM
- 0.502
- EPSDynamic
- 0.481
- EPSStatic
- --
- BVPS
- 6.47
- P/B
- 0.85
- HK Shares
- 108.00M
- Dividend YieldTTM
- 6.26%
- DividendTTM
- 0.343531
- Shares
- 108.00M
- Min lot size
- 500
- Currency
- HKD
CHARMACY PHAR Analyst Rating
View moreForecast & Rating
Aug 10, 2018Price forecast
--100.00%
Forecast & RatingBuy
1analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
- Strong buy
- 0
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong sell
- 0
News
PUBT · Charmacy Pharmaceutical FY26 H1 net profit rises 3.76% to RMB 22.56 million; revenue climbs 13.6% to RMB 2.45 billion
PUBT · Charmacy Pharmaceutical schedules board meeting to review interim results, dividend option
Tip Ranks · Charmacy Pharmaceutical Corrects EPS and ROE Note in 2025 Results
AASTOCKS · "Performance" CHARMACY PHAR's annual net profit is 46.2729 million RMB, down 13.2%, with a final dividend of 0.30 RMB
Tip Ranks · Charmacy Pharmaceutical Profit Slips in 2025 but Dividend Held
Tip Ranks · Charmacy Pharmaceutical Sets Board Meeting to Approve 2025 Results and Consider Final Dividend
